# Allogeneic Stem Cell Transplantation for Patients With Severe Aplastic Anemia

> **NCT00578266** · PHASE1 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 8 (actual)

## Conditions studied

- Anemia, Aplastic

## Interventions

- **DRUG:** Cyclophosphamide,Campath IH and TBI

## Key facts

- **NCT ID:** NCT00578266
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-02
- **Primary completion:** 2016-08-16
- **Final completion:** 2016-08-16
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2017-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00578266

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00578266, "Allogeneic Stem Cell Transplantation for Patients With Severe Aplastic Anemia". Retrieved via AI Analytics 2026-08-23 from https://api.ai-analytics.org/clinical/NCT00578266. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*